Annual report pursuant to Section 13 and 15(d)

Finance leases receivable (Details Narrative)

v3.24.1
Finance leases receivable (Details Narrative) - USD ($)
1 Months Ended 12 Months Ended
Jul. 11, 2023
Sep. 27, 2022
Oct. 31, 2022
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2020
Dec. 31, 2019
Sep. 30, 2022
Aug. 31, 2022
Aug. 27, 2021
Apr. 24, 2019
Finance lease impairment             $ 783,880        
Selling, general and administrative expenses       $ 1,775,210 $ 495,400            
Lease equipment at cost           $ 622,569          
G Farma Settlors [Member]                      
Litigation Settlement, Amount Awarded from Other Party $ 2,539,597     2,539,597              
Litigation settlement default amount 2,494,450                    
Litigation Settlement Interest 40,219     120,370              
Litigation Settlement, Expense 1,643                    
Legal Fees $ 3,285                    
Debt Instrument, Interest Rate, Effective Percentage 10.00%                    
Partner II [Member]                      
Finance lease revenue       $ 0 $ 37,659            
Settlement agreement and mutual release [Member] | G Farma Settlors [Member]                      
Liability for Unpaid Claims and Claims Adjustment Expense, Adjustments     $ 2,000,000         $ 2,000,000 $ 2,000,000 $ 2,000,000  
Remaining amount     494,450                
Liability for Unpaid Claims and Claims Adjustment Expense, Net     500,000         500,000 500,000 $ 500,000  
Liability for accrued unpaid interest     $ 2,000,000         $ 2,000,000 $ 2,000,000    
Bad debt expenses [Member]                      
Selling, general and administrative expenses           19,519          
G FarmaLabs Limited [Member] | Mentor partner I [Member]                      
Cost of impounded assets                     $ 427,804
G Farmas [Member]                      
Proceeds from sale of lease receivables           $ 348,734          
Pueblo West Organics, LLC [Member]                      
Payments to acquire machinery and equipment   $ 245,369